Get the latest news about Guerbet

New indication in pediatric patients, including term neonates for Guerbet’s half-dose GBCA, Elucirem™ (Gadopiclenol) Injection

Guerbet Visibly Different

Karim Boussebaa Appointed Chief Executive Officer of Guerbet

Guerbet gets CDP's A- rating for its commitment to the fight against global warming

U.S. FDA Approves Guerbet's Optiray® (Ioversol Injection) Imaging Bulk Package

Guerbet Sponsors 2020 National Radiologic Technology Week

American Board of Artificial Intelligence in Medicine (ABAIM) Aims to Educate and Certify Healthcare Professionals in AI, and Related Technologies

Guerbet Announces FDA Approval to manufacture Dotarem® (gadoterate meglumine) injection in the United States

Guerbet Announces AHRA Charitable Contribution